Table 1 Study participants’ characteristic
Variables | Normal (n = 98) | COPD (n = 63) | PRISm (n = 33) | P value |
|---|---|---|---|---|
Sex, n (%) | ||||
 Male | 49 (50.0%) | 53 (84.1%) | 19 (57.6%) | .000 |
 Female | 49 (50.0%) | 10 (15.9%) | 14 (42.4%) |  |
 Age (years) | 54.72 ± 14.00 | 67.63 ± 9.79 | 59.15 ± 15.60 | .000 |
 BMI (kg/m2) | 24.35 ± 3.39 | 24.03 ± 3.27 | 24.05 ± 3.91 | .487 |
Smoking, n (%) | ||||
 Never | 69 (70.4%) | 22 (34.9%) | 18 (54.5%) | .000 |
 Former | 9 (9.2%) | 24 (38.1%) | 8 (24.2%) |  |
 Current | 20 (20.4%) | 17 (27.0%) | 7 (21.2%) |  |
 Previous diagnosis of COPD | 2 (2.0%) | 18 (28.6%) | 3 (9.1%) | .000 |
 Bronchodilators have been used, n (%) | 15 (15.3%) | 26 (41.3%) | 5 (15.2%) | .000 |
Comorbidities, n (%) | ||||
 Hypertension | 28 (28.6%) | 25 (39.7%) | 17 (51.5%) | .046 |
 Diabetes | 10 (10.2%) | 7 (11.1%) | 5 (15.1%) | .739 |
 CHD | 9 (9.2%) | 9 (14.3%) | 6 (18.1%) | .340 |
 Tumor | 1 (1.0%) | 3 (4.8%) | 1 (3.0%) | .338 |
 Previous asthma | 5 (5.1%) | 2 (3.2%) | 4 (12.1%) | .186 |
 CAT score | 11.16 ± 5.40 | 13.90 ± 6.53 | 14.42 ± 7.00 | .010 |
 SGRQ score | 20.05 ± 10.43 | 29.95 ± 14.44 | 27.55 ± 15.24 | .000 |